<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(8)</volume><submitter>Yu X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Mediated by innate immune cells, inflammation is an underlying presence in the pathogenesis of numerous pulmonary diseases. Macrophages play a critical role in mediating the initial response to infection in the lungs. When there is excessive activation of macrophages, hyper-production of inflammatory factors occurs, with inflammation as the ultimate result. Wogonoside, a bioactive flavonoid glycoside, has been reported to alleviate pulmonary inflammation. However, the mechanism underlying the anti-inflammatory effect of wogonoside has not yet been clarified.&lt;h4>Methods&lt;/h4>The productions of nitric oxide (NO) and reactive oxygen species (ROS) were determined using a Griess reagent kit and a DAF-FM DA fluorescent probe, respectively. Moreover, the mRNA levels of inflammat</pubmed_abstract><journal>Annals of translational medicine</journal><pagination>532</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7214906</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway.</pubmed_title><pmcid>PMC7214906</pmcid><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Qiu C</pubmed_authors><pubmed_authors>Khan K</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Luo H</pubmed_authors><pubmed_authors>Yu X</pubmed_authors><pubmed_authors>Chen D</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway.</name><description>&lt;h4>Background&lt;/h4>Mediated by innate immune cells, inflammation is an underlying presence in the pathogenesis of numerous pulmonary diseases. Macrophages play a critical role in mediating the initial response to infection in the lungs. When there is excessive activation of macrophages, hyper-production of inflammatory factors occurs, with inflammation as the ultimate result. Wogonoside, a bioactive flavonoid glycoside, has been reported to alleviate pulmonary inflammation. However, the mechanism underlying the anti-inflammatory effect of wogonoside has not yet been clarified.&lt;h4>Methods&lt;/h4>The productions of nitric oxide (NO) and reactive oxygen species (ROS) were determined using a Griess reagent kit and a DAF-FM DA fluorescent probe, respectively. Moreover, the mRNA levels of inflammat</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Apr</publication><modification>2025-04-25T19:35:39.719Z</modification><creation>2025-04-06T08:02:15.144Z</creation></dates><accession>S-EPMC7214906</accession><cross_references><pubmed>32411755</pubmed><doi>10.21037/atm.2020.04.22</doi></cross_references></HashMap>